Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK)

医学 胰岛素 冲程(发动机) 内科学 随机对照试验 优势比 相伴的 临床终点 麻醉 机械工程 工程类
作者
Christopher S. Gray,Anthony J. Hildreth,Peter Sandercock,Janice O’Connell,Donna E Johnston,NIALL E. F. CARTLIDGE,John Bamford,Oliver James,K. G. M. M. Alberti
出处
期刊:Lancet Neurology [Elsevier BV]
卷期号:6 (5): 397-406 被引量:613
标识
DOI:10.1016/s1474-4422(07)70080-7
摘要

Summary Background Hyperglycaemia after acute stroke is a common finding that has been associated with an increased risk of death. We sought to determine whether treatment with glucose-potassium-insulin (GKI) infusions to maintain euglycaemia immediately after the acute event reduces death at 90 days. Methods Patients presenting within 24 h of stroke onset and with admission plasma glucose concentration between 6·0–17·0 mmol/L were randomly assigned to receive variable-dose-insulin GKI (intervention) or saline (control) as a continuous intravenous infusion for 24 h. The purpose of GKI infusion was to maintain capillary glucose at 4–7 mmol/L, with no glucose intervention in the control group. The primary outcome was death at 90 days, and the secondary endpoint was avoidance of death or severe disability at 90 days. Additional planned analyses were done to determine any differences in residual disability or neurological and functional recovery. The trial was powered to detect a mortality difference of 6% (sample size 2355), with 83% power, at the 5% two-sided significance level. This study is registered as an International Standard Randomised Controlled Trial (number ISRCTN 31118803) Findings The trial was stopped due to slow enrolment after 933 patients were recruited. For the intention-to-treat data, there was no significant reduction in mortality at 90 days (GKI vs control: odds ratio 1·14, 95% CI 0·86–1·51, p=0·37). There were no significant differences for secondary outcomes. In the GKI group, overall mean plasma glucose and mean systolic blood pressure were significantly lower than in the control group (mean difference in glucose 0·57 mmol/L, p Interpretation GKI infusions significantly reduced plasma glucose concentrations and blood pressure. Treatment within the trial protocol was not associated with significant clinical benefit, although the study was underpowered and alternative results cannot be excluded.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CipherSage应助As采纳,获得10
刚刚
jnshen发布了新的文献求助30
刚刚
科研通AI5应助何lalala采纳,获得10
刚刚
珏珏子发布了新的文献求助10
1秒前
安在哉发布了新的文献求助10
1秒前
蓟野完成签到,获得积分20
1秒前
迷路世立完成签到,获得积分10
1秒前
搜集达人应助健忘的含卉采纳,获得10
1秒前
2秒前
冷静的飞丹完成签到,获得积分10
2秒前
852应助小v1212采纳,获得10
2秒前
3秒前
科研通AI5应助oookkay采纳,获得10
3秒前
科研通AI5应助求学采纳,获得10
3秒前
科研通AI5应助Oreki采纳,获得10
3秒前
天天快乐应助sdl采纳,获得10
4秒前
jhlz5879完成签到,获得积分10
4秒前
英姑应助小帕采纳,获得10
4秒前
狂野剑心完成签到,获得积分10
4秒前
阿牛完成签到,获得积分10
4秒前
5秒前
马马马完成签到,获得积分10
5秒前
松柏发布了新的文献求助10
5秒前
cx完成签到 ,获得积分10
6秒前
紫色风铃完成签到,获得积分10
6秒前
6秒前
6秒前
6秒前
默默地读文献应助关二哥采纳,获得10
6秒前
xeiwei完成签到,获得积分10
7秒前
7秒前
网友小根完成签到,获得积分10
7秒前
jming87完成签到,获得积分10
7秒前
Hezhiyong发布了新的文献求助10
8秒前
乐观期待完成签到,获得积分10
8秒前
发财总发布了新的文献求助30
8秒前
饭饭完成签到,获得积分10
9秒前
春天在这李完成签到,获得积分10
9秒前
9秒前
852应助好运藏在善良里采纳,获得10
9秒前
高分求助中
All the Birds of the World 4000
Production Logging: Theoretical and Interpretive Elements 3000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Machine Learning Methods in Geoscience 1000
Resilience of a Nation: A History of the Military in Rwanda 888
Essentials of Performance Analysis in Sport 500
Measure Mean Linear Intercept 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3730023
求助须知:如何正确求助?哪些是违规求助? 3274861
关于积分的说明 9989324
捐赠科研通 2990315
什么是DOI,文献DOI怎么找? 1641017
邀请新用户注册赠送积分活动 779534
科研通“疑难数据库(出版商)”最低求助积分说明 748237